FDA Issues Warning Letter to Allovate Therapeutics
October 15, 2025
October 15, 2025
WASHINGTON, Oct. 15 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Allovate Therapeutics LLC from the Center for Biologics Evaluation and Research:
* * *
Recipient: William Reisacher, MD, Senior Scientific Advisor and Co-Founder, Allovate Therapeutics, LLC, 20 W 125th St #1, New York, NY 10027, United States, wir2011@med.cornell.edu
Issuing Office: Center for Biologics Evaluation and R . . .
* * *
Recipient: William Reisacher, MD, Senior Scientific Advisor and Co-Founder, Allovate Therapeutics, LLC, 20 W 125th St #1, New York, NY 10027, United States, wir2011@med.cornell.edu
Issuing Office: Center for Biologics Evaluation and R . . .